Open AccessAstraZeneca COVID ‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
Author(s) -
Siddig Amira,
Abbasher Hussien Mohamed Ahmed Khabab,
Hassan Haroun Mazin S.,
M. Abdallah Abdallah,
Malekaldar Mohamed,
Abbasher Al Hussien,
Abbasher Mohammed,
Abbasher Abubaker Alsedig,
Hussien Abbasher
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6017
Subject(s) - medicine , covid-19 , stroke (engine) , ischemic stroke , venous thrombosis , cerebral venous sinus thrombosis , cardiology , thrombosis , ischemia , disease , infectious disease (medical specialty) , mechanical engineering , engineering
One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID‐19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID‐19 vaccine, indicating a relationship between the AstraZeneca COVID‐19 vaccine and these conditions.